Sanofi Uses $21.2B cash, CVR to Win Grande Dame Genzyme
By Tom Wall
Thursday, February 17, 2011
In the end, all it took was more cash now, and a shot at more cash later, for French suitor Sanofi-Aventis SA to win over Genzyme Corp., one of the grande dames of U.S. biotechnology.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.